That Cancer Conversation · 2026-02-19 · 49 min
What if our blood could help us detect cancer earlier than ever before? In this episode, we’re exploring liquid biopsies, cutting-edge blood tests that can pick up the smallest signs of cancer swirling through the blood. We sit down with Professor Nitzan Rosenfeld, Director of Barts Cancer Institute and a pioneer in the field. Professor Rosenfeld explains how fragments of tumour DNA enter our blood from cancer cells, what they can tell us about cancer, and how liquid biopsies can use blood samples to transform early detection, screening and treatment. Don't forget to like, subscribe and hit that notification bell to hear about new episodes!
Other episodes covering the same guests and topics, from across The B2B Podcast Index.
How Targeted Radiotherapy Is Changing Cancer Care w/ John Babich, President, CSO, Ratio TherapeuticsCareTalk: Healthcare. Unfiltered. · on cancer94 / 100
#192 - Slowing Things Down to Speed Up Research with Jared Forney of OktaAwkward Silences · on research90 / 100
Why your research needs a “thinking cave” with Sarah KlingThe Curiosity Current: A Market Research Podcast · on research89 / 100
The Safest of Them All: What If Safe Assets Aren't Safe? (ft. Vincent Mortier, Group CIO of Amundi and Deputy CEO of Amundi AM)2050 Investors · on research81 / 100
Rapid Response: OpenAI’s Critterz blowback - Director Nik Kleverov on year zero for HollywoodPioneers of AI · on science76 / 100
Building Self-Accelerating AI with MirendilAI + a16z · on research65 / 100
